We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

70 hedge funds and large institutions have $309M invested in Ocular Therapeutix in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 7 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

414% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 7

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

6% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 16

1% less funds holding

Funds holding: 71 → 70 (-1)

19% less capital invested

Capital invested by funds: $380M → $309M (-$71.1M)

20% less call options, than puts

Call options by funds: $650K | Put options by funds: $814K

Holders
70
Holders Change
-1
Holders Change %
-1.41%
% of All Funds
1.95%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
15
Increased
36
Reduced
7
Closed
16
Calls
$650K
Puts
$814K
Net Calls
-$164K
Net Calls Change
-$164K

Top Buyers

Rank Fund Capital Flow
1
VVM
Versant Venture Management
California
+$44.5M
2
LCP
Lamond Capital Partners
California
+$10.5M
3
PCM
Portolan Capital Management
Massachusetts
+$7.43M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$7.21M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.89M

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$6.22M
2
SFM
Sphera Funds Management
Israel
-$3.37M
3
DCM
Driehaus Capital Management
Illinois
-$2.96M
4
ARTA
A.R.T. Advisors
New York
-$1.42M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.02M +$381K +18,942 +35%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$960K +$85.8K +4,269 +7%
CCI
28
Columbus Circle Investors
$930K +$1.33M +66,112 New
NIP
29
Nicholas Investment Partners
California
$881K +$1.26M +62,669 New
AllianceBernstein
30
AllianceBernstein
Tennessee
$823K +$935K +46,544 +388%
TCIM
31
TIAA CREF Investment Management
New York
$815K +$118K +5,879 +11%
BIM
32
BlackRock Investment Management
Delaware
$735K +$123K +6,132 +13%
FAM
33
Fred Alger Management
New York
$496K – – –
USAA
34
United Services Automobile Association
Texas
$481K -$33.2K -1,650 -5%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$384K +$70.3K +3,500 +15%
EDRH
36
Edmond de Rothschild Holding
Switzerland
$380K +$543K +27,000 New
EDRS
37
Edmond de Rothschild (Suisse)
Switzerland
$380K +$543K +27,000 New
Wells Fargo
38
Wells Fargo
California
$302K +$106K +5,263 +33%
AC
39
Amici Capital
New York
$281K – – –
TA
40
Teachers Advisors
New York
$267K – – –
Charles Schwab
41
Charles Schwab
California
$262K – – –
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$228K +$110K +5,456 +51%
NFA
43
Nationwide Fund Advisors
Ohio
$196K +$17.2K +856 +7%
CIA
44
Capital Impact Advisors
Massachusetts
$186K – – –
Swiss National Bank
45
Swiss National Bank
Switzerland
$183K +$44.2K +2,200 +20%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$165K +$29K +1,444 +14%
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
$163K -$1.41M -70,061 -86%
EIM
48
Essex Investment Management
Massachusetts
$161K +$231K +11,485 New
TI
49
Trexquant Investment
Connecticut
$151K -$99K -4,928 -31%
CCM
50
Coe Capital Management
Illinois
$141K +$201K +10,000 New
1
2
3 4

OCUL Hedge Fund Activity: Q3 2015 in Review

70 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q3 2015, worth a combined $309M — down 19% from $380M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of OCUL and 15 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 36 added.

The largest buyer was Versant Venture Management, opening a new position worth an estimated $44.5M. The largest seller was Pentwater Capital Management, exiting entirely with an estimated $6.22M sold.

  • 70 institutional investors held Ocular Therapeutix (OCUL) as of Q3 2015, down from 71 in Q2 2015.
  • Funds reported $309M of Ocular Therapeutix stock for Q3 2015, down 19% quarter-over-quarter.
  • 15 funds opened new Ocular Therapeutix positions in Q3 2015 and 16 closed out, a net change of -1 holder.
  • The largest Ocular Therapeutix buyer in Q3 2015 was Versant Venture Management, an estimated $44.5M added.
  • The largest Ocular Therapeutix seller in Q3 2015 was Pentwater Capital Management, an estimated $6.22M sold.

Based on aggregated 13F filings for Q3 2015.